Literature DB >> 28895298

Two decades of dendrimers as versatile MRI agents: a tale with and without metals.

Michael T McMahon1,2, Jeff W M Bulte1,2,3,4,5,6.   

Abstract

Dendrimers or dendritic polymers are a class of compounds with great potential for nanomedical use. Some of their properties, including their rigidity, low polydispersity and the ease with which their surfaces can be modified make them particularly well suited for use as MRI diagnostic or theranostic agents. For the past 20 years, researchers have recognized this potential and refined dendrimer formulations to optimize these nanocarriers for a host of MRI applications, including blood pool imaging agents, lymph node imaging agents, tumor-targeted theranostic agents and cell tracking agents. This review summarizes the various types of dendrimers according to the type of MR contrast they can provide. This includes the metallic T1 , T2 and paraCEST imaging agents, and the non-metallic diaCEST and fluorinated (19 F) heteronuclear imaging agents. This article is categorized under: Diagnostic Tools > In Vivo Nanodiagnostics and Imaging Implantable Materials and Surgical Technologies > Nanomaterials and Implants.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28895298      PMCID: PMC5989322          DOI: 10.1002/wnan.1496

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  131 in total

1.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Authors:  Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

2.  Dendrimeric calcium-responsive MRI contrast agents with slow in vivo diffusion.

Authors:  Serhat Gündüz; Nobuhiro Nitta; Sandip Vibhute; Sayaka Shibata; Martin E Mayer; Nikos K Logothetis; Ichio Aoki; Goran Angelovski
Journal:  Chem Commun (Camb)       Date:  2015-02-18       Impact factor: 6.222

3.  Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Sang-Kyung Jo; Henry L Bryant; Martin W Brechbiel; Robert A Star
Journal:  Bioconjug Chem       Date:  2003 Mar-Apr       Impact factor: 4.774

4.  Chemical Exchange Saturation Transfer (CEST) Agents: Quantum Chemistry and MRI.

Authors:  Jikun Li; Xinxin Feng; Wei Zhu; Nikita Oskolkov; Tianhui Zhou; Boo Kyung Kim; Noman Baig; Michael T McMahon; Eric Oldfield
Journal:  Chemistry       Date:  2015-11-30       Impact factor: 5.236

5.  Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Authors:  Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

6.  Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.

Authors:  Mingqian Tan; Zhen Ye; Daniel Lindner; Susann M Brady-Kalnay; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2013-03-08       Impact factor: 4.200

7.  Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Robert A Star; Thomas A Waldmann; Yutaka Tagaya; Martin W Brechbiel
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

8.  MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain.

Authors:  Jeff W M Bulte; Tamir Ben-Hur; Bradley R Miller; Rachel Mizrachi-Kol; Ophira Einstein; Etti Reinhartz; Holly A Zywicke; Trevor Douglas; Joseph A Frank
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

9.  Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer.

Authors:  Kangan Li; Shihui Wen; Andrew C Larson; Mingwu Shen; Zhuoli Zhang; Qian Chen; Xiangyang Shi; Guixiang Zhang
Journal:  Int J Nanomedicine       Date:  2013-07-19

10.  Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma.

Authors:  Ruizhi Wang; Yu Luo; Shuohui Yang; Jiang Lin; Dongmei Gao; Yan Zhao; Jinguo Liu; Xiangyang Shi; Xiaolin Wang
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

View more
  6 in total

Review 1.  Application of Dendrimers in Anticancer Diagnostics and Therapy.

Authors:  Zuzanna Bober; Dorota Bartusik-Aebisher; David Aebisher
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

Review 2.  Polyphosphorhydrazone-Based Radical Dendrimers.

Authors:  Vega Lloveras; José Vidal-Gancedo
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

Review 3.  19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Authors:  Yanan Li; Jing Cui; Chenlong Li; Huimin Zhou; Jun Chang; Omer Aras; Feifei An
Journal:  ChemMedChem       Date:  2022-01-12       Impact factor: 3.540

Review 4.  Applications and Limitations of Dendrimers in Biomedicine.

Authors:  Adriana Aurelia Chis; Carmen Dobrea; Claudiu Morgovan; Anca Maria Arseniu; Luca Liviu Rus; Anca Butuca; Anca Maria Juncan; Maria Totan; Andreea Loredana Vonica-Tincu; Gabriela Cormos; Andrei Catalin Muntean; Maria Lucia Muresan; Felicia Gabriela Gligor; Adina Frum
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

Review 5.  Dendrimers: A New Race of Pharmaceutical Nanocarriers.

Authors:  Pooja Mittal; Anjali Saharan; Ravinder Verma; Farag M A Altalbawy; Mohammed A Alfaidi; Gaber El-Saber Batiha; Wahida Akter; Rupesh K Gautam; Md Sahab Uddin; Md Sohanur Rahman
Journal:  Biomed Res Int       Date:  2021-02-15       Impact factor: 3.411

6.  Investigation of the Associations between a Nanomaterial's Microrheology and Toxicology.

Authors:  Romi Singh Maharjan; Ajay Vikram Singh; Javaria Hanif; Daniel Rosenkranz; Rashad Haidar; Amruta Shelar; Shubham Pratap Singh; Aditya Dey; Rajendra Patil; Paolo Zamboni; Peter Laux; Andreas Luch
Journal:  ACS Omega       Date:  2022-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.